 - Patients who have had chemotherapy or radiotherapy or biologic agents within 4 weeks 6 weeks for nitrosoureas or mitomycin C prior to entering the study or those who have not recovered from adverse events due to agents administered more than 4 weeks earlier; at least 4 weeks must have elapsed since any major surgery 